WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles

New stock news | Siasun Robot&Automation applies to the Hong Kong Stock Exchange again, as the leading provider of industrial intelligent mobile solutions in China for Siasun Robot&Automation.

New stock news | Wanheng Energy submits application to Hong Kong Stock Exchange

SKB BIO-B (06990): The application for clinical trial of ITGB6 ADC SKB105 new drug has been approved by the National Medical Products Administration.
New stock news | Siasun Robot&Automation applies to the Hong Kong Stock Exchange again, as the leading provider of industrial intelligent mobile solutions in China for Siasun Robot&Automation.

New stock news | Wanheng Energy submits application to Hong Kong Stock Exchange

SKB BIO-B (06990): The application for clinical trial of ITGB6 ADC SKB105 new drug has been approved by the National Medical Products Administration.






